RAMANDEEP AULAKH: Open Payments
NPI 1326277153 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 91 payments from 15 companies in 2025. Trend: 2023 $889 · 2024 $1,371 · 2025 $1,408
Food & beverage: $1,408
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 41 | $436 |
| AstraZeneca Pharmaceuticals LP | 10 | $259 |
| GlaxoSmithKline, LLC. | 11 | $172 |
| PFIZER INC. | 11 | $157 |
| ABBVIE INC. | 3 | $74 |
| Sumitomo Pharma America, Inc. | 3 | $66 |
| Exact Sciences Corporation | 2 | $59 |
| Novo Nordisk Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $29 |
Products named: OTEZLA, TRELEGY ELLIPTA, BREZTRI, FARXIGA, NURTEC ODT, UBRELVY, GEMTESA, REXULTI.
Industry payments across CA — which companies pay providers there.
